Timothy Hoey, SVP, Cancer Biology at OncoMed Pharmaceuticals Inc (OMED), sold 4,323 shares at $22.30 ($96K) on 2016-01-06, disclosed to the SEC on 2016-01-08.
Open-market sale of $96k OMED by SVP, Cancer Biology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.56 | 69 | $1K | 1.5% |
| 2 | $21.56 | 69 | $1K | 1.5% |
| 3 | $22.30 | 2,092 | $47K | 48.4% |
| 4 | $22.30 | 2,092 | $47K | 48.4% |
| 5 | $21.33 | 1 | $21 | 0.0% |
| Total | $22.28 avg | 4,323 |
| $96K |
| 100% |
| Filing → |
| TNYA | SELL | 2024-02-16 | $27K | — | Filing → |
| TNYA | SELL | 2023-08-29 | $31K | — | Filing → |
| TNYA | SELL | 2023-08-18 | $15K | — | Filing → |